Eligible costs of rescEU medical aerial evacuation, emergency medical team type 2 and type 3, medical stockpiling, CBRN decontamination, CBRN stockpiling, temporary shelter, transport, logistics, CBRN detection, sampling, identification and monitoring, and mobile laboratory capacities
Article 1
Implementing Decision (EU) 2019/570 is amended as follows: (1) in Article 1a, the following point 4 is added: ‘(4) “reach back” means the process of obtaining support from entities that are not deployed in the field.’; (2) in Article 2, paragraph 2 is amended as follows: (a) point (j) is replaced by the following: ‘(j) transport and logistics capacities;’; (b) the following points are added: ‘(k) CBRN detection, sampling, identification and monitoring capacities for the response to emergencies, for search activities, for the response to security events, and for the surveillance of major events; (l) mobile laboratory capacities.’; (3) Article 3a is replaced by the following: ‘Article 3a Eligible costs of rescEU medical aerial evacuation, emergency medical team type 2 and type 3, medical stockpiling, CBRN decontamination, CBRN stockpiling, temporary shelter, transport, logistics, CBRN detection, sampling, identification and monitoring, and mobile laboratory capacities All cost categories referred to in Annex Ia to Decision No 1313/2013/EU shall be taken into account when calculating the total eligible cost of rescEU capacities.’; (4) in Article 3e, paragraphs 3 and 4 are replaced by the following: ‘3. rescEU capacities referred to in points (c) to (l) of Article 2(2) shall be established with the objective of managing low probability risks with a high impact. 4. Where rescEU capacities referred to in points (c) to (l) of Article 2(2) are deployed under the Union Mechanism, Union financial assistance shall cover 100 % of the operational costs, pursuant to Article 23(4b) of Decision No 1313/2013/EU.’; (5) the Annex is amended in accordance with the Annex to this Decision.